Josh and Jason are joined this week by Kris Bryant, current president of the Pediatric Infectious Diseases Society. Our discussion ranges from fellowship and recruitment in the context of Covid-19 to how to address structural racism as a pediatric infectious diseases community.

Josh and Jason are joined this week by Andrej Spec to discuss more about the data coming out on remdesivir, specifically the recently release trial examining 5 days of therapy versus 10 days. They also hit on how we are all connected through health and the need for justice.

Josh and Jason return to podcasting and discuss the recently released New England Journal paper on remdesivir for Covid-19.